News

Mesoblast posted a decisive second fiscal quarter: Ryoncil gross sales reached $35 million with net revenue of $30 million,...

Scilex Holding Company has made a $20 million strategic investment in Quantum Scan Holdings, a medical technology firm developing...

Avicanna has published prospective real-world evidence from a physician-supervised medical cannabis program in the Canadian Journal of Pain, reporting...

Regeneron posted a muted top line for 2025—fourth quarter revenue up 3% to $3.9 billion and full-year up 1%...

Achieve Life Sciences has granted stock options covering 115,000 shares to five new employees under its 2024 equity inducement...

Nurix Therapeutics has dosed the first patients in DAYBREAK, its registrational program for bexobrutideg (NX-5948) in relapsed/refractory chronic lymphocytic...

Belite Bio will showcase previously disclosed topline results from its Phase 3 DRAGON trial of tinlarebant in adolescents with...

CorMedix will host an in‑person and virtual analyst day on February 10 to showcase its post‑acquisition growth plan, centering...

Sanofi closed 2025 with a strong fourth quarter: net sales rose 13.3% at constant exchange rates to €11.3 billion...

Roche closed 2025 with 7% group sales growth at constant exchange rates, powered by a 9% rise in Pharmaceuticals...